top of page

Pravin Dugel on taking the job of executive chairman at Ocular Therapeutix

He describes what made him excited about the company, and why he views diabetic retinopathy as potentially an even bigger opportunity than wet AMD.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page